| abstract |
The present invention relates to a) a compound of formula (I) wherein (for preferred compounds only) THF is tetrahydrofuryl; R1 is carbonyl or -O-CO-; D and D 'are independently an optionally substituted aromatic or non-aromatic carbocyclic or heterocyclic group, a substituted or fused carbocyclic group, or an alkyl or alkenyl group optionally substituted with such or other groups; and Ehalogen, hydroxy, methoxy, amino, acetylamino, methylthio or methyl-substituted or heterocycle-fused phenyl aspartyl protease inhibitor sulfonamides, b) one or more other antiviral agents and c) a pharmaceutically acceptable carrier, a binder or other excipient or adjuvant, provided that it is different from the other protease inhibitor of the other antiviral agent. |